These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19555668)

  • 1. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
    Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
    Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
    Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
    Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
    Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.
    Salminen O; Murphy KL; McIntosh JM; Drago J; Marks MJ; Collins AC; Grady SR
    Mol Pharmacol; 2004 Jun; 65(6):1526-35. PubMed ID: 15155845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release.
    Cao YJ; Surowy CS; Puttfarcken PS
    Neuropharmacology; 2005 Jan; 48(1):72-9. PubMed ID: 15617729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
    Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
    Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient binding of 4/7 α-conotoxins to nicotinic α4β2 receptors is prevented by Arg185 and Pro195 in the α4 subunit.
    Beissner M; Dutertre S; Schemm R; Danker T; Sporning A; Grubmüller H; Nicke A
    Mol Pharmacol; 2012 Oct; 82(4):711-8. PubMed ID: 22802270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK; Sumithran SP; Dwoskin LP
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
    Eaton MJ; Ospina CA; Rodríguez AD; Eterović VA
    Neurosci Lett; 2004 Aug; 366(1):97-102. PubMed ID: 15265598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex.
    Drew AE; Derbez AE; Werling LL
    Synapse; 2000 Oct; 38(1):10-6. PubMed ID: 10941136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.
    Luo S; Kulak JM; Cartier GE; Jacobsen RB; Yoshikami D; Olivera BM; McIntosh JM
    J Neurosci; 1998 Nov; 18(21):8571-9. PubMed ID: 9786965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI; Reid RT; Santori EM; Adams P; Correa LD; Mahaffy LS; Bleicher L; Cosford ND; Stauderman KA; McDonald IA; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):373-83. PubMed ID: 8996218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.